Literature DB >> 9640539

Co-activators and co-repressors in the integration of transcriptional responses.

J Torchia1, C Glass, M G Rosenfeld.   

Abstract

The nuclear hormone receptors are DNA binding transcription factors that are regulated by binding of ligands, switching them from an inactive or repressive state to gene-activating functions. Recent evidence supports the hypothesis that many nuclear receptors switch, in a ligand-dependent manner, between binding of a multicomponent co-repressor complex containing histone deacetyltransferase activity, and binding of a co-activator complex containing factors with histone acetyltransferase activity that are further regulated by diverse signal transduction pathways. The identification of these limiting co-repressor and co-activator complexes and their specific interaction motifs, in concert with solution of the structures of the receptor ligand-binding domain in apo (empty) and ligand bound forms, indicates a common molecular mechanism by which these factors activate and repress gene transcription.

Mesh:

Substances:

Year:  1998        PMID: 9640539     DOI: 10.1016/s0955-0674(98)80014-8

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  143 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Functional analysis of the SIN3-histone deacetylase RPD3-RbAp48-histone H4 connection in the Xenopus oocyte.

Authors:  D Vermaak; P A Wade; P L Jones; Y B Shi; A P Wolffe
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Transcriptional activation by NF-kappaB requires multiple coactivators.

Authors:  K A Sheppard; D W Rose; Z K Haque; R Kurokawa; E McInerney; S Westin; D Thanos; M G Rosenfeld; C K Glass; T Collins
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Modulation of CRX transactivation activity by phosducin isoforms.

Authors:  X Zhu; C M Craft
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

5.  Unique forms of human and mouse nuclear receptor corepressor SMRT.

Authors:  P Ordentlich; M Downes; W Xie; A Genin; N B Spinner; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Factor-specific modulation of CREB-binding protein acetyltransferase activity.

Authors:  V Perissi; J S Dasen; R Kurokawa; Z Wang; E Korzus; D W Rose; C K Glass; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.

Authors:  D Zerby; C J Chen; E Poon; D Lee; R Shiekhattar; P M Lieberman
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

8.  Thyroid hormone, T3-dependent phosphorylation and translocation of Trip230 from the Golgi complex to the nucleus.

Authors:  Y Chen; P L Chen; C F Chen; Z D Sharp; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

9.  DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription.

Authors:  F Ledo; A M Carrión; W A Link; B Mellström; J R Naranjo
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

10.  Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development.

Authors:  L M Sachs; Y B Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.